Chengdu Busheng Investment

The firm's strategy spans early-stage seed, start-up, and expansion or late-stage venture, indicating a full-lifecycle mandate. This structure allows it to invest at company formation and continue through subsequent growth rounds. The coverage suggests Busheng positions as a patient capital provider rather than a single-check, seed-only investor.

Given the firm's sole Chengdu location and absence of a public-facing digital presence, deal flow likely originates through regional networks, local government industrial-policy channels, and entrepreneur referrals within the Chengdu-Chongqing corridor. The firm's hyper-local footprint implies sourcing is concentrated in Sichuan's state-backed innovation parks and university spin-out ecosystems.

The firm's registered strategy is generalist. In the context of Chinese regional VC, this often translates to a multi-sector mandate covering deeptech, advanced manufacturing, life sciences, and enterprise software — sectors aligned with provincial economic development priorities. No specific sector exclusions are publicly declared.

No, the firm does not publicly disclose assets under management or total capital deployed. Its AUM band is unverifiable from open sources as of mid-2026. This opacity is consistent with many Chinese regional asset managers whose limited-partner base is entirely domestic and not subject to public-reporting norms.

The firm's named principals, investment committee members, and governance structure are not publicly disclosed. No key-person information appears in the available public record, including firm-originated communications, regulatory filings, or third-party data platforms.